{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-086685","form_type":"8-K","ticker":"HEPA","cik":"0001583771","company_name":"Hepion Pharmaceuticals, Inc.","filed_at":"2022-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.256490+00:00","generated_at":"2026-06-24T03:20:34.776914+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Hepion shareholders reject authorized share increase from 120M to 200M","bullets":["Proposal received 19,267,720 For, 27,847,827 Against, 254,176 Abstain; broker non-votes 1.","The amendment to the certificate of incorporation was not approved.","Meeting was previously adjourned to complete voting on this proposal."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-086685","json":"https://secwatch.observer/filing/0001104659-22-086685.json","markdown":"https://secwatch.observer/filing/0001104659-22-086685.md","text":"https://secwatch.observer/filing/0001104659-22-086685.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583771/000110465922086685/0001104659-22-086685-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583771/000110465922086685/tm2222710d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T03:20:34.776914+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}